IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 10

Issue Published : 113

Article Submitted : 18006

Article Published : 7746

Total Authors : 20484

Total Reviewer : 747

Total Countries : 140

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Analytical Method Development and Validation for Simultaneous Estimation of Olanzapine and Escitalopram Oxalate in bulk pharmaceutical dosage form by RP-HPLC Method.
Authors Name: Rupali Kobarne , Manish Raskar , Pallavi Jadhav
Download E-Certificate: Download
Author Reg. ID:
IJRTI_184588
Published Paper Id: IJRTI2211045
Published In: Volume 7 Issue 11, November-2022
DOI:
Abstract: A simple, sensitive, accurate, precise, linear, reproducible, ecofriendly, economic and fast HPLC method has been developed. The proposed method was validated for according to ICH guidelines. Reverse phase HPLC method has been developed for simultaneous estimation of anti-psychotic drug Olanzapine and antidepressant drug Escitalopram Oxalate in bulk drug and dosage forms. The mobile phase used for to developed the method was Methanol: Water (80:20 v/v). The flow rate of mobile phase delivery is 1.0 ml/min. at a wavelength detection at 217nm. The retention time of Olanzapine and Escitalopram Oxalate were 2.21 min 3.09 min. respectively. The developed method was accurately validated follows all the guidelines prescribed by the ICH. The proposed method used for determination of concentration of these drugs in bulk and combined dosage forms.
Keywords: RP-HPLC, Olanzapine, Escitalopram oxalate, Validation and Pharmaceuticals.
Cite Article: "Analytical Method Development and Validation for Simultaneous Estimation of Olanzapine and Escitalopram Oxalate in bulk pharmaceutical dosage form by RP-HPLC Method.", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.7, Issue 11, page no.306 - 311, November-2022, Available :http://www.ijrti.org/papers/IJRTI2211045.pdf
Downloads: 000205277
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2211045
Registration ID:184588
Published In: Volume 7 Issue 11, November-2022
DOI (Digital Object Identifier):
Page No: 306 - 311
Country: Ahmednagar, Maharastra, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2211045
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2211045
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED, Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Join RMS/Earn 300

IJRTI

WhatsApp
Click Here

Indexing Partner